The metastatic triple-negative breast cancer (MTNBC) treatment market has been witnessing significant growth in the recent years. MTNBC refers to an aggressive type of breast cancer that tests negative for estrogen and progesterone receptors, and lacks excess HER2 protein. Patients of MTNBC have higher chances of disease recurrence and reduced survival rates than other types of breast... https://www.zupyak.com/p/4474381/t/metastatic-triple-negative-breast-cancer-mtnbc-market-advancements-driving-market-growth